SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-004525
Filing Date
2024-04-01
Accepted
2024-04-01 16:08:19
Documents
83
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20231231x10k.htm   iXBRL 10-K 1608758
2 EX-21.1 tmb-20231231xex21d1.htm EX-21.1 3477
3 EX-23.1 tmb-20231231xex23d1.htm EX-23.1 14553
4 EX-31.1 tmb-20231231xex31d1.htm EX-31.1 14308
5 EX-31.2 tmb-20231231xex31d2.htm EX-31.2 14526
6 EX-32.1 tmb-20231231xex32d1.htm EX-32.1 7623
7 EX-32.2 tmb-20231231xex32d2.htm EX-32.2 7595
8 EX-97 tmb-20231231xex97.htm EX-97 39886
  Complete submission text file 0001558370-24-004525.txt   6560235

Data Files

Seq Description Document Type Size
9 EX-101.SCH tmb-20231231.xsd EX-101.SCH 44892
10 EX-101.CAL tmb-20231231_cal.xml EX-101.CAL 45631
11 EX-101.DEF tmb-20231231_def.xml EX-101.DEF 147252
12 EX-101.LAB tmb-20231231_lab.xml EX-101.LAB 403516
13 EX-101.PRE tmb-20231231_pre.xml EX-101.PRE 305337
87 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231231x10k_htm.xml XML 971430
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 24809234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)